Literature DB >> 29549391

Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.

Asti Jackson1, Roger L Papke2, M Imad Damaj3.   

Abstract

RATIONALE: Recent preclinical data has implicated the α7 nicotinic acetylcholine receptor (nAChR) as a target in modulating nicotine reward. However, the role of the channel properties of the α7 nAChR in nicotine withdrawal is unknown.
OBJECTIVES: This study aimed to investigate the impact of α7 nAChR pharmacological modulation on mecamylamine-precipitated nicotine withdrawal behaviors in mice by using positive allosteric modulators (PAMs).
METHODS: The effect of the orthosteric α7 nAChR full agonist PNU282987 (1, 3, 9 mg/kg, s.c.), type I α7 PAM NS1738 (1 and 10 mg/kg; i.p.) and the type II α7 PAM PNU120596 (3 and 9 mg/kg, i.p.) on anxiety-like behavior, somatic signs, and hyperalgesia was measured in mice undergoing mecamylamine-precipitated nicotine withdrawal. Mice were infused with 24 mg/kg/day nicotine or saline for 14 days using s.c. osmotic minipumps. Nicotine withdrawal signs were precipitated upon administration of the non-selective nAChR antagonist mecamylamine (3.5 mg/kg, i.p.).
RESULTS: Anxiety-like behavior in nicotine withdrawn mice was only attenuated by PNU282987 in a dose-related fashion. Somatic signs were reduced by PNU282987 and NS1738. PNU120596 was the only compound that reversed precipitated nicotine withdrawal-induced hyperalgesia.
CONCLUSIONS: Taken together, our results suggest that modulation of the α7 nAChR can play important roles in mecamylamine-precipitated nicotine withdrawal behaviors in mice. In addition, the effects of PAMs in this study suggest that endogenous acetylcholine/choline tone is sufficient to attenuate some aspects of precipitated nicotine withdrawal. These findings highlight a beneficial effect of using α7 nAChR PAMs in some aspects of precipitated nicotine withdrawal.

Entities:  

Keywords:  Mecamylamine-precipitated nicotine withdrawal; Mouse model; Nicotinic acetylcholine receptor; PAMs

Mesh:

Substances:

Year:  2018        PMID: 29549391      PMCID: PMC6015775          DOI: 10.1007/s00213-018-4879-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  35 in total

1.  Smoking cessation among self-quitters.

Authors:  J R Hughes; S B Gulliver; J W Fenwick; W A Valliere; K Cruser; S Pepper; P Shea; L J Solomon; B S Flynn
Journal:  Health Psychol       Date:  1992       Impact factor: 4.267

2.  Investigation of the molecular mechanism of the α7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states.

Authors:  Dustin K Williams; Jingyi Wang; Roger L Papke
Journal:  Mol Pharmacol       Date:  2011-09-01       Impact factor: 4.436

Review 3.  Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations.

Authors:  Dustin K Williams; Jingyi Wang; Roger L Papke
Journal:  Biochem Pharmacol       Date:  2011-05-14       Impact factor: 5.858

4.  The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat.

Authors:  A Markou; N E Paterson
Journal:  Nicotine Tob Res       Date:  2001-11       Impact factor: 4.244

5.  Nicotine physical dependence in the mouse: involvement of the alpha7 nicotinic receptor subtype.

Authors:  Sheri D Grabus; Billy R Martin; M Imad Damaj
Journal:  Eur J Pharmacol       Date:  2005-05-16       Impact factor: 4.432

6.  Characterization of spontaneous and precipitated nicotine withdrawal in the mouse.

Authors:  M I Damaj; W Kao; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  2003-09-11       Impact factor: 4.030

7.  Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test.

Authors:  J D Brioni; A B O'Neill; D J Kim; M W Decker
Journal:  Eur J Pharmacol       Date:  1993-07-06       Impact factor: 4.432

8.  Effects of α7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models.

Authors:  Kelen Freitas; Sudeshna Ghosh; F Ivy Carroll; Aron H Lichtman; M Imad Damaj
Journal:  Neuropharmacology       Date:  2012-10-16       Impact factor: 5.250

9.  The antinociceptive effects of nicotinic receptors α7-positive allosteric modulators in murine acute and tonic pain models.

Authors:  Kelen Freitas; F Ivy Carroll; M Imad Damaj
Journal:  J Pharmacol Exp Ther       Date:  2012-10-31       Impact factor: 4.030

10.  Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors.

Authors:  Nicole L Yohn; Jill R Turner; Julie A Blendy
Journal:  J Pharmacol Exp Ther       Date:  2014-03-13       Impact factor: 4.030

View more
  7 in total

Review 1.  Recent findings in the pharmacology of inhaled nicotine: Preclinical and clinical in vivo studies.

Authors:  Asti Jackson; Ben Grobman; Suchitra Krishnan-Sarin
Journal:  Neuropharmacology       Date:  2020-06-24       Impact factor: 5.250

2.  Impact of modulation of the α7 nicotinic acetylcholine receptor on nicotine reward in the mouse conditioned place preference test.

Authors:  Asti Jackson; Y Alkhlaif; R L Papke; D H Brunzell; M I Damaj
Journal:  Psychopharmacology (Berl)       Date:  2019-07-13       Impact factor: 4.530

3.  Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats.

Authors:  Adam Kimbrough; Jenni Kononoff; Sierra Simpson; Marsida Kallupi; Sharona Sedighim; Kenia Palomino; Dana Conlisk; Jeremiah D Momper; Giordano de Guglielmo; Olivier George
Journal:  Psychopharmacology (Berl)       Date:  2020-02-29       Impact factor: 4.530

Review 4.  More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.

Authors:  M J Moerke; L R McMahon; J L Wilkerson
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

Review 5.  Rodent models for nicotine withdrawal.

Authors:  Ranjithkumar Chellian; Azin Behnood-Rod; Dawn M Bruijnzeel; Ryann Wilson; Vijayapandi Pandy; Adriaan W Bruijnzeel
Journal:  J Psychopharmacol       Date:  2021-04-22       Impact factor: 4.562

6.  Analysis of the brain transcriptome in lines of laying hens divergently selected for feather pecking.

Authors:  Clemens Falker-Gieske; Andrea Mott; Siegfried Preuß; Sören Franzenburg; Werner Bessei; Jörn Bennewitz; Jens Tetens
Journal:  BMC Genomics       Date:  2020-08-27       Impact factor: 3.969

Review 7.  New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence.

Authors:  Rocio Saravia; Marc Ten-Blanco; Inmaculada Pereda-Pérez; Fernando Berrendero
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.